Fundamental Analysis of Core Laboratories NV - Growth / Value Index
CLB - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0.819
Tremendous increasing in Book Value last 3 year
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 20.82 | 21.22 | -51.76 % | |
| Price to Book | 3.88 | 3.71 | -18.05 % | 3.67 |
| Price to Sales | 1.70 | 1.70 | -2.48 % | |
| Enterprise Value to EBITDA Multiple | 11.62 | 12.42 | -29.13 % |
CLB - Profitability Highlights
Profitability Analysis
Piotroski F Score - Good Value of 7.0
Annual Net Profit in last 3 years is trending up
EBITDA is continuously increasing for last 3 Years
Good Return on Equity of 18.89% is achieved by the company
Tsr Profitability Index - Poor Score of 25.66
Very Low Dividend Yield of 0.220 %
Low Earning Yield of 4.78 %
EPS decline for last four quarters
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 18.89 | 17.49 | 69.89 % | 1.39 |
| Return On Asset | 7.04 | 6.91 | 105.39 % | 0.548 |
| Net Profit Margin | 8.18 | 8.03 | 102.17 % | 2.48 |
| Operating Profit Margin | 11.24 | 10.55 | 24.44 % | 7.26 |
| EBITDA Margin | 14.28 | 13.65 | 14.29 % | 10.23 |
Highlights
| Market Cap | 853025 K |
| Enterprise Value | 848080 K |
| Price/Book TTM | 3.88 |
| Outstanding Share | 46664.40 K |
| Float/ Outstanding Share | 99.61% |
| Dividend Yield | 0.220 % |
Share Holding
Guru Numbers
| Price/Graham No | 1.85 |
| Peter Lynch Ratio | 5.15 |
| Piotroski F Score | 7.00 |
| Altman Z Score | 2.87 |
| Sloan Ratio | 0.0273 |
| Peter Lynch Fair Value | 0 |
CLB - Growth Highlights
Growth Analysis
YoY Net Margin Jump by 102.17%
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Poor Score of 29.01
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 511071 K | 4.10 % | 1.11 % |
| Gross Profit | 92471.00 K | 19.17 % | 7.07 % |
| EBITDA | 73003.00 K | 18.97 % | 26.45 % |
| Net Profit | 41786.00 K | 110.45 % | 50.18 % |
| EPS | 0.878 | 107.31 % | NA |
CLB - Stability Highlights
Stability Analysis
Tsr Stability Index - Good Score of 76.56
Paid More Than 50% of Debt, Heading towards debt free
Debt to equity ratio has decreased and is lowest in last five years
Decreasing debt with Increasing revenue
Company financial liquidity has improved
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.0435 | -95.54 % | 0.0449 |
| Cash Ratio | 0.173 | 15.55 % | |
| Quick Ratio | 1.73 | 17.91 % | 1.85 |
| Shareholders Equity | 39.50 | 20.90 % | |
| Debt to EBITDA | 0.146 | -95.35 % |
Historical Valuation Ratios of Core Laboratories NV
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Core Laboratories NV
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Core Laboratories NV
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Core Laboratories NV
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)